BioSpace News Archive

Isometric Business people pushing cubes. Winner easily moving the cube. Winning strategy, efficiency, innovation in business concept

Diabetes

ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval

Newly approved weight loss pill Foundayo reduced blood sugar more than Novo Nordisk’s semaglutide and other comparators in multiple Phase 3 type 2 diabetes trials. Eli Lilly will seek approval in this indication.

June 9, 2026

·

2 min read

·

Tristan Manalac

Big fish with a dollar badge wants to eat small fish

Mergers & acquisitions

GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year

Nuvalent Bio is GSK’s third big-ticket purchase this year, after the pharma dropped $2.2 billion in January for RAPT Therapeutics and $950 million in February for 35Pharma.

June 9, 2026

·

2 min read

·

Tristan Manalac

Two businessman taking competition.Overtaking

Weight loss

ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data

AstraZeneca is pushing its small molecule GLP-1 drug to Phase 3 development for weight control, diabetes and other cardiometabolic conditions despite the asset failing to best one from Structure Therapeutics.

June 9, 2026

·

1 min read

·

Tristan Manalac

Seamless gummy bears pattern with pink and blue jelly candy shapes on a bright pink background. Sweet repeating confectionery texture for packaging, wrapping paper, textiles, stationery and prints.

HIV

Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble

While Merck and Gilead Sciences reported back-to-back late-stage victories for their weekly HIV pill, the partners also discontinued a Phase 3 program for their cancer combo after disappointing lung cancer survival data.

June 9, 2026

·

2 min read

·

Tristan Manalac

financial problem, businesswoman is confused to see the missing business income coin faucet, losses in business are caused by poor financial management

Venture capital

Four years and 219 lost companies later, biotech still has a cash problem

The public biotech universe has shrunk by more than 20% since 2021, yet financial stress remains entrenched across the sector, according to a report from EY Tuesday.

June 9, 2026

·

3 min read

·

Ana Mulero

Photo of pinned Columbus on a map of USA. May be used as illustration for traveling theme.

Manufacturing

Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs

The money will enable the addition of aseptic filling and oral solid dose capabilities to support Hikma’s products and contract manufacturing clients.

June 9, 2026

·

1 min read

·

Nick Paul Taylor

Press Releases

Adaptyx Biosciences Presents First In-Human Continuous Multi-Day Free Cortisol Data From a Wearable Sensor at ADA, Providing a Time-resolved View of the Hormone Signal Driving Glucose Control, Cardiovascular Health, Stress Response, and Sleep

June 9, 2026

·

8 min read

Press Releases

GENFIT: NASHnext®, Powered by GENFIT’s Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH